WEBSITE BSE:543951 NSE : INNOVATUS 17 May, 11:35
Market Cap ₹14 Cr.
Stock P/E
P/B 1.1
Current Price ₹34.8
Book Value ₹ 31.8
Face Value 10
52W High ₹57.8
Dividend Yield 0%
52W Low ₹ 26.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|
Net Sales | 10 | 8 | 8 | 11 | |
Other Income | 0 | 0 | 0 | 0 | |
Total Income | 10 | 8 | 8 | 11 | |
Total Expenditure | 10 | 7 | 7 | 10 | |
Operating Profit | 1 | 1 | 1 | 1 | |
Interest | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | 0 | 0 | 0 | 1 | |
Provision for Tax | 0 | 0 | 0 | 0 | |
Profit After Tax | 0 | 0 | 0 | 0 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 0 | 0 | 0 | 0 | |
Adjusted Earnings Per Share | 1.5 | 1.7 | 1.5 | 2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 38% | 3% | 0% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 13% | 15% | 16% | 16% |
ROCE Average | 13% | 13% | 16% | 16% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Shareholder's Funds | 2 | 2 | 2 | 5 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 0 | 2 | 2 | 2 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
Total Current Liabilities | 3 | 2 | 1 | 2 |
Total Liabilities | 4 | 6 | 5 | 8 |
Fixed Assets | 2 | 1 | 1 | 1 |
Other Non-Current Assets | 0 | 0 | 0 | 0 |
Total Current Assets | 3 | 5 | 4 | 7 |
Total Assets | 4 | 6 | 5 | 8 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | 0 | -2 | 0 | -1 |
Cash Flow from Investing Activities | -0 | 0 | 0 | 0 |
Cash Flow from Financing Activities | 0 | 2 | 0 | 2 |
Net Cash Inflow / Outflow | 0 | -0 | 0 | 1 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 1 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Earnings Per Share (Rs) | 1.46 | 1.66 | 1.5 | 2 |
CEPS(Rs) | 3.31 | 3.38 | 2.64 | 2.78 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 8.54 | 10.2 | 11.7 | 20.06 |
Core EBITDA Margin(%) | 7.31 | 10.14 | 8 | 7.58 |
EBIT Margin(%) | 3.74 | 5.73 | 5.11 | 5.88 |
Pre Tax Margin(%) | 3.74 | 5.73 | 5.11 | 5.88 |
PAT Margin (%) | 2.83 | 4.26 | 3.83 | 4.41 |
Cash Profit Margin (%) | 6.39 | 8.66 | 6.72 | 6.12 |
ROA(%) | 6.55 | 6.38 | 5.35 | 7.13 |
ROE(%) | 17.16 | 17.73 | 13.72 | 13.43 |
ROCE(%) | 22.74 | 17 | 10.81 | 12.57 |
Receivable days | 97.75 | 173.76 | 204.89 | 178.66 |
Inventory Days | 0 | 0 | 0 | 0 |
Payable days | 0 | 0 | 0 | 0 |
PER(x) | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | -0.01 | 0.19 | 0.44 | 0.29 |
EV/Core EBITDA(x) | -0.12 | 1.87 | 5.44 | 3.8 |
Net Sales Growth(%) | 0 | -24.76 | 0.49 | 38.84 |
EBIT Growth(%) | 0 | 15.22 | -10.48 | 59.75 |
PAT Growth(%) | 0 | 13.38 | -9.56 | 59.85 |
EPS Growth(%) | 0 | 13.38 | -9.56 | 33.32 |
Debt/Equity(x) | 0 | 0.74 | 0.65 | 0.32 |
Current Ratio(x) | 1.11 | 2.11 | 3.38 | 4.31 |
Quick Ratio(x) | 1.11 | 2.11 | 3.38 | 4.31 |
Interest Cover(x) | 0 | 0 | 0 | 0 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# | Sep 2023 | Mar 2024 |
---|---|---|
Promoter | 60.87 | 60.87 |
FII | 0 | 0 |
DII | 0 | 0 |
Public | 39.13 | 39.13 |
Others | 0 | 0 |
Total | 100 | 100 |
# | Sep 2023 | Mar 2024 |
---|---|---|
Promoter | 0.24 | 0.24 |
FII | 0 | 0 |
DII | 0 | 0 |
Public | 0.15 | 0.15 |
Others | 0 | 0 |
Total | 0.4 | 0.4 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About